Europe Negative Pressure Wound Therapy Market - Industry Analysis and Market Forecast (2022 - 2027)

The Europe Negative Pressure Wound Therapy Market is Segmented by Product (Re-Usable Device and Single-Use Device) Wound Type, End-User, and by Geography

Market Snapshot

Europe Negative Pressure Wound Therapy Market Size
Study Period: 2017-2025
Base Year: 2021
CAGR: 5.6 %
Europe Negative Pressure Wound Therapy Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Negative pressure wound therapy is considered to be the most preferred choice of treatment, especially for deep acute wounds and persistent chronic wounds including leg ulcers. The topical use of NPWT has been widely studied in the literature over the past 20 years. Most clinical trials have shown the effectiveness of this therapy in the treatment of superficial wounds. Moreover, the localized use of NPWT in infected wounds offers advantages, such as wound drainage, angiogenesis stimulation, proteinase excretion, and decreased local and systemic bacterial load. 

Therefore the increasing prevalence of chronic wounds and diabetic ulcers in the region and technological advancements in the NPWT devices are fueling the market growth. However the high cost of the treatment and complications associated with the NPWT devices are major restraints for the growth of the market in the region.

Scope of the report

As per the scope of the report negative-pressure wound therapy (NPWT) is a therapeutic technique using a suction dressing to remove excess exudation and promote healing in acute or chronic wounds and second- and third-degree burns. This report covers the study of types of NPWT products and their applications across various injuries/ulcers.

By Product
Re-Usable Device
Single-Use Device
By Wound Type
Diabetic Foot Ulcer
Pressure Ulcer
Venous Leg Ulcer
Burn Wounds
By End-User
United Kingdom
Rest of Europe

Report scope can be customized per your requirements. Click here.

Key Market Trends

Diabetic Foot Ulcers are Expected to Witness Rapid Growth in the Market Studied

Diabetic Foot Ulcers (DFU) is one of the most common complications associated with Diabetes and is posing a huge burden on several countries across the European region. The diabetic foot ulcer occurs in approximately 15 percent of patients with diabetes, and therefore the increasing diabetic population in the region is contributing to the dominant share of the segment. According to the International Diabetes Federation, 2019, there are about 59 million people with diabetes in the European Region or about 10.3% of men and 9.6% of women aged 20–79 years. The prevalence of diabetes is increasing among all ages in the European Region, mostly due to increases in overweight and obesity, unhealthy diet, and physical inactivity. Thus owing to the increasing prevalence of diabetes and diabetic foot ulcer, the market is expected to grow over the forecast period.

Europe Negative Pressure Wound Therapy Market Share

Europe Negative Pressure Wound Therapy Market Growth

Competitive Landscape

The Europe Negative Pressure Wound Therapy Market is moderately competetive with several major players. Some of the strategies implemented include agreements, collaborative models, business expansion, and product developments. Some of the major players are Molnlycke Health Care, ConvaTec Inc., Cardinal Health, Inc., Smith & Nephew plc, 3M.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Number of Accidents and Traumatic Events

      2. 4.2.2 Rising Chronic Wounds Such as Diabetic Foot Ulcers

      3. 4.2.3 Technological Advancements in the NPWT Devices

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Device and Treatment

      2. 4.3.2 Complications Associated With NPWT Device

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 Re-Usable Device

      2. 5.1.2 Single-Use Device

    2. 5.2 By Wound Type

      1. 5.2.1 Diabetic Foot Ulcer

      2. 5.2.2 Pressure Ulcer

      3. 5.2.3 Venous Leg Ulcer

      4. 5.2.4 Burn Wounds

      5. 5.2.5 Others

    3. 5.3 By End-User

      1. 5.3.1 Hospital

      2. 5.3.2 Homecare

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe


    1. 6.1 Company Profiles

      1. 6.1.1 Molnlycke Health Care

      2. 6.1.2 ConvaTec Inc.

      3. 6.1.3 Cardinal Health, Inc.

      4. 6.1.4 Smith & Nephew plc

      5. 6.1.5 3M (Acelity L.P. Inc.)

      6. 6.1.6 Talley Group Limited

      7. 6.1.7 Devon Medical, Inc

      8. 6.1.8 Medela AG

      9. 6.1.9 DeRoyal Industries, Inc.

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Europe Negative Pressure Wound Therapy Market market is studied from 2017 - 2025.

The Europe Negative Pressure Wound Therapy Market is growing at a CAGR of 5.6% over the next 5 years.

Molnlycke Health Care, ConvaTec Inc., Cardinal Health, Inc., Smith & Nephew plc, 3M (Acelity L.P. Inc.) are the major companies operating in Europe Negative Pressure Wound Therapy Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!